2001
DOI: 10.1148/radiol.2211991748
|View full text |Cite
|
Sign up to set email alerts
|

Case 39: Invasive Lobular Carcinoma

Abstract: The patient was a 43-year-old woman, otherwise healthy, who presented with a palpable mass in the entire upper right breast, centered at the 12-o'clock position. She also had vague thickening of the upper left breast at the radiologist's clinical examination. IMAGING FINDINGSPreliminary clinical examination findings demonstrated a broad, approximately 7 ϫ 8-cm area of palpable thickening in the upper right breast extending from the 9-through the 3-o'clock position. Bilateral mediolateral oblique and craniocaud… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2006
2006
2013
2013

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 30 publications
(40 reference statements)
0
4
0
Order By: Relevance
“…ILC has been traditionally described as histologically and clinically distinct from IDC, and has been associated with a worse overall prognosis. Microscopically, ILC is characterized by hyperchromatic, spindle‐shaped or round cells forming linear invasive columns classically described as “Indian filing” (3), whereas IDC more typically presents as a discrete cluster of cells forming a mass, and is more often associated with micro‐calcifications. ILC frequently invades the normal tissues without inducing the intense desmoplastic response that commonly accompanies IDC.…”
mentioning
confidence: 99%
“…ILC has been traditionally described as histologically and clinically distinct from IDC, and has been associated with a worse overall prognosis. Microscopically, ILC is characterized by hyperchromatic, spindle‐shaped or round cells forming linear invasive columns classically described as “Indian filing” (3), whereas IDC more typically presents as a discrete cluster of cells forming a mass, and is more often associated with micro‐calcifications. ILC frequently invades the normal tissues without inducing the intense desmoplastic response that commonly accompanies IDC.…”
mentioning
confidence: 99%
“…Another reasonable diagnostic option in the absence of mass or microcalcifications on mammography and the palpable tumor is infiltrating lobular carcinoma, but the ultrasonography showed absence of posterior shadowing and linear tracts, not supporting the diagnosis [1].…”
Section: Discussionmentioning
confidence: 95%
“…E-cadherin is normally expressed in the majority (50%-65%) of NLCs, and although it does not have a true tumor suppressor role in this group, E-cadherin loss is associated with poorer prognostic features, including larger size, higher tumor grade, development of metastases, a basal phenotype, and triple negativity (4,5,11). The effect of E-cadherin loss on normal cell adhesion is thought to have a role in the characteristic histologic appearance of ILC of loosely dispersed linear columns of cells, unlike the typical discrete mass in invasive ductal cancer (6). This more diffuse infiltrative pattern of tumor morphologic features may explain some of the typical imaging appearances of ILC, such as reduced conspicuity at mammography and US.…”
Section: E-cadherin Is a Cell-adhesion Molecule Expressed In Normal Bmentioning
confidence: 98%
“…-cadherin is a cell adhesion molecule expressed in normal breast tissue but typically absent in most (84%-100%) invasive lobular cancers (ILCs) (1)(2)(3) and reduced or absent in 35%-50% of nonlobular cancers (NLCs) (4,5). In ILC, E-cadherin is a tumor suppressor gene and absent expression is considered to lead to their characteristic pathologic growth pattern of infiltrative linear columns of discohesive cells, rather than the more well-circumscribed discrete mass of cohesive cells usually seen in invasive ductal cancer (6). This, in addition to the known reduced rate of microcalcification in ILC, influences their appearance at imaging, with often reduced conspicuity at both mammography and ultrasonography (US).…”
mentioning
confidence: 99%